AZISIGN 250 Tablet by Dr Precision is a potent macrolide antibiotic featuring 250 mg of Azithromycin per tablet, specifically designed to combat a wide range of bacterial infections. With its broad-spectrum efficacy, AZISIGN 250 targets respiratory infections including pharyngitis, tonsillitis, bronchitis, and community-acquired pneumonia, as well as skin and soft tissue infections such as cellulitis and impetigo. The tablet also effectively treats ENT infections like sinusitis and otitis media and certain urogenital infections caused by Chlamydia trachomatis. AZISIGN 250 is formulated for optimal patient adherence with its once-daily dosing and shortened treatment duration of 3 to 5 days, supported by Azithromycin's long half-life and superior tissue penetration. Manufactured under rigorous GMP standards by Dr Precision, this antibiotic guarantees reliable quality suitable for hospital and outpatient use. Its rapid absorption, reaching peak plasma concentrations within 2 to 3 hours, ensures fast therapeutic action, while sustained tissue levels maintain effectiveness post-treatment, making AZISIGN 250 an ideal choice for healthcare providers seeking both efficacy and convenience in antibacterial therapy.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Azithromycin 250 mg per tablet |
| Antibacterial Spectrum | Broad-spectrum macrolide effective against respiratory, skin, ENT, and urogenital infections |
| Dosage Regimen | Once-daily dosing with a short treatment duration of 3-5 days |
| Pharmacokinetics | Rapid absorption with peak plasma levels in 2-3 hours; long half-life enabling sustained tissue concentration |
| Manufacturing Standard | Produced under GMP-compliant conditions by Dr Precision |
| Indications | Treatment of pharyngitis, tonsillitis, bronchitis, community-acquired pneumonia, cellulitis, impetigo, sinusitis, otitis media, and urogenital infections |
| Patient Compliance | Enhanced by once-daily dosing and shorter treatment duration |
| Mechanism of Action | Inhibits bacterial protein synthesis by binding to 50S ribosomal subunit |
| Formulation | Tablet for oral administration |
| Use Settings | Suitable for hospital and outpatient treatments |
| Attributes | Description |
|---|---|
| Tablet Strength | 250 mg Azithromycin |
| Formulation Type | Oral Tablet |
| Dosage Frequency | Once daily |
| Treatment Duration | 3 to 5 days |
| Pharmacological Class | Macrolide antibiotic |
| Absorption | Rapid oral absorption with peak plasma concentration in 2-3 hours |
| Half-Life | Extended, supporting sustained tissue presence |
| Manufacturing Standards | GMP-compliant |
| Indications | Respiratory tract, skin, ENT, and some urogenital bacterial infections |
| Packaging | Available in blister packs |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
AZISIGN 250 Tablet features an extended half-life of azithromycin, allowing for once-daily dosing and shorter treatment durations (3-5 days), which significantly improves patient compliance compared to antibiotics requiring multiple daily doses.
Yes, AZISIGN 250 is manufactured under GMP-compliant conditions ensuring high quality and reliability, making it suitable for use in both hospital and outpatient environments.
Its excellent tissue penetration, especially in inflamed areas such as sinuses and middle ear, ensures effective drug concentration at the infection site, improving therapeutic outcomes.
Yes, AZISIGN 250 is indicated for certain urogenital infections such as uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis.
Azithromycin in AZISIGN 250 binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting bacterial protein synthesis, thereby preventing growth and replication.
Country Of Origin: India
AZISIGN 250 Tablet contains Azithromycin 250 mg, a broad-spectrum macrolide antibiotic used to treat a variety of bacterial infections. It is effective against respiratory tract infections, skin infections, ear infections, and certain sexually transmitted diseases. With its convenient once-daily dosing and short treatment duration, AZISIGN 250 offers excellent patient compliance. Manufactured under stringent GMP standards, AZISIGN 250 Tablet provides reliable, high-quality antibacterial therapy for both outpatient and hospital settings.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
AZISIGN 250 Tablet is a high-quality macrolide antibiotic manufactured to address a broad spectrum of bacterial infections effectively. Each tablet contains 250 mg of Azithromycin, an active pharmaceutical ingredient well-regarded for its powerful antibacterial properties. Azithromycin is a semisynthetic derivative of erythromycin and has a broader antimicrobial spectrum along with better tissue penetration and improved pharmacokinetic properties. It works by binding to the 50S ribosomal subunit of susceptible bacteria, thereby inhibiting bacterial protein synthesis. This process prevents the bacteria from growing and replicating, allowing the immune system to clear the infection more efficiently.
AZISIGN 250 is prescribed for the treatment of numerous bacterial infections, particularly those affecting the respiratory system, including pharyngitis, tonsillitis, bronchitis, and community-acquired pneumonia. It is also widely used for skin and soft tissue infections such as cellulitis, impetigo, and infected wounds. In ENT infections, including sinusitis and otitis media, Azithromycin proves to be a dependable choice due to its ability to reach effective concentrations in inflamed tissues. Moreover, it is indicated for certain urogenital infections, including uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis.
One of the key advantages of AZISIGN 250 is its extended half-life, which allows for once-daily dosing and shorter treatment durations, typically ranging from three to five days. This unique feature enhances patient compliance and therapeutic outcomes, particularly when compared to antibiotics that require multiple daily doses over longer periods. The drug is absorbed quickly when taken orally and reaches peak plasma levels within two to three hours. It accumulates effectively in tissues such as the lungs, tonsils, and skin, maintaining bactericidal concentrations for several days even after the final dose.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
